[Helicobacter pylori: screen and treat?].
Current evidence assigns to the Helicobacter pylori infection an essential role and major risk in gastric carcinogenesis. In high risk groups and populations a H. pylori screen-and-treat strategy is recommended and already implemented in some countries. A general screen-and-treat is the way to go as it may reduce the burden of gastric cancer for the community and prevent deleterious individual destinies.
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Otto-von-Guericke Universität Magdeburg.
P
P
Malfertheiner
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005753:Gastric Mucosa / Q000382:microbiology; D005756:Gastritis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008403:Mass Screening; D010437:Peptic Ulcer / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D013274:Stomach Neoplasms / Q000209:etiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents